Post-streptococcal glomerulonephritis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 9: Line 9:
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
The incidence of post-streptococcal glomerulonephritis is approximately 10 to 29 per 100,000 individuals worldwide.
The incidence of post-streptococcal glomerulonephritis is approximately 9.5 to 28.5 per 100,000 individuals worldwide.<ref name="pmid16253886">{{cite journal |vauthors=Carapetis JR, Steer AC, Mulholland EK, Weber M |title=The global burden of group A streptococcal diseases |journal=Lancet Infect Dis |volume=5 |issue=11 |pages=685–94 |date=November 2005 |pmid=16253886 |doi=10.1016/S1473-3099(05)70267-X |url=}}</ref>


===Prevalence===
===Prevalence===

Revision as of 13:52, 21 May 2018

Post-streptococcal glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Post-streptococcal glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Post-streptococcal glomerulonephritis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Post-streptococcal glomerulonephritis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Post-streptococcal glomerulonephritis epidemiology and demographics

CDC on Post-streptococcal glomerulonephritis epidemiology and demographics

Post-streptococcal glomerulonephritis epidemiology and demographics in the news

Blogs on Post-streptococcal glomerulonephritis epidemiology and demographics

Directions to Hospitals Treating Post-streptococcal glomerulonephritis

Risk calculators and risk factors for Post-streptococcal glomerulonephritis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

Epidemiology and Demographics

Incidence

The incidence of post-streptococcal glomerulonephritis is approximately 9.5 to 28.5 per 100,000 individuals worldwide.[1]

Prevalence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
  • The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

The incidence of post-streptococcal glomerulonephritis increases in older people age greater than 60 years and children with age between 5 to 12 years.

Race

  • There is no racial predilection to [disease name].
  • [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

Mens are more commonly affected by post-streptococcal glomerulonephritis than women.

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

References

  1. Carapetis JR, Steer AC, Mulholland EK, Weber M (November 2005). "The global burden of group A streptococcal diseases". Lancet Infect Dis. 5 (11): 685–94. doi:10.1016/S1473-3099(05)70267-X. PMID 16253886.

Template:WH